Iimiphumo zesondlo eziqhelekileyo eziqhelekileyo kunye ne-SSRI izidakamizwa
Isihlunu kunye nokuhlanza zimbini zeempembelelo eziqhelekileyo eziqhelekileyo ezichasayo, kwaye kungathatha ixesha lokugqithisa le mpawu xa uqala unyango. Enyanisweni, isisulu sokubamba isantya sisoloko sisiphumo esisinye sempembelelo ezininzi ze -serotonin reuptake inhibitors (i-SSRIs) esetyenziselwa ukunyamezela ukudakumba okukhulu kunye nokukhathazeka okukhulu .
Uphando olwenziwe ngu-US Food and Drug Information lucacisa ukuba umngcipheko wee-nudea ezinxulumene ne-SSRI ziyahluka ukusuka phezulu ukuya phezulu:
- I-Paxil (i-paroxetine) : 3.2%
- Celexa (citalopram) : 4%
- Lexapro (escitalopram): 15%
- Iprozac (i-fluoxetine) : 21%
- Zoloft (sertraline) : 26%
- Luvox (i-fluvoxamine) : 40%
Kwezinye iimeko, isicupunu kunye nokuhlanza kunokuba nzima kakhulu okanye kuqhubekeka ukuba umntu akanakho enye indlela kodwa ukuyeka unyango.
Ukujamelana Neengxaki kunye nokuVothela
Kwiimeko ezininzi, isicupunu kunye nokuhlanza ezinxulumene nezidandlululo ziza kuphucula emva kweveki okanye ezimbini. Nangona kunjalo, abaninzi abantu abangama-32 abadlulileyo banokufumana isantya esithile sokubanjelwa isicathulo seenyanga ezintathu.
Ukuba i-nasusea iqhubeka, kukho izinto ezininzi onokukwazi ukulawula iimpawu. Phakathi kwabo:
- Thatha i-antidepressant yakho yokutya.
- Yidla amancinci, ukutya okudla rhoqo.
- Ukuphumelela kwi-candy kanzima engashatswanga nantoni naxa unesiqhelo.
- Sebenzisa i-subsalicylate ye-antacid okanye ibismuth (njengePepto-Bismol).
- I-tea ye-ginger ye-ginger okanye i-ginger ale encinci.
- Thatha i-antidepressant yakho ngexesha lokulala.
- I-Zantac (ranitidine), i-anti-counter-counter-acacid, xa ifunekayo;
- Thatha ifom ekhutshwa ngokukhawuleza ye-antidepressant yakho.
- Buza ugqirha wakho ukuba anciphise umlinganiselo wakho wexeshana.
Ugqirha wakho unokukwazi ukumisela imithi yokulwa neengcambu ezifana neZofran (ondansetron) okanye iprot pump inhibitor ezifana ne-Prilosec (omeprazole).
Ukuba ugqirha wakho uchaza iproton pump inhibitor, thabatha njengoko ulandisiweyo.
Iproton pump inhibitors inokunyusa izinga lokuxilongwa kwegazi lama-SSRI athile kwaye, kwezinye iimeko, zifuna ukunciphisa umlinganiselo we-antidepressant dosage.
Njalo ucebise ugqirha wakho ukuba uthatha nayiphi na iyeza-counter-counter-counter okanye isongezelelo ukunyanga isicupunu okanye ukuhlanza.
Xa Iziphumo Zecala Zingenakuxolisa
Ukuba isicathulo sakho okanye ukuhlanza singenakuxinwa, ugqirha wakho unokungabi nalunye ukhetho kodwa utshintshe unyango komnye umntu ogxininisekile kunye nomngcipheko we-nausea ophantsi ((njengeCelexa, Paxil, okanye Symbrax).
Kubalulekile, nangona kunjalo, ungalokothi unqande unyango okanye unciphise umlinganiselo wakho ngaphandle kokubonisana nodokotela wakho kuqala. Ukuba wenza njalo, ubeka umngcipheko wokubuya okanye ukugqithisa kweempawu zokudandatheka.
Ukongezelela, unokufumana iimpawu zokurhoxisa ngokuqhelekileyo ekubhekiselwe kuzo njenge- syndrome ye-anti-depressant syndrome (ADS) . I-ADS idla ngohlobo lweentsholongwane xa iqalisa kuqala kodwa inokukhula ngokukhawuleza kwiimpawu ezinokukhubaza, ezifana ne:
- I sizathu
- Ukuvutha
- Ukukhathala
- Ubuhlungu besisu
- Ukungabikho
- Utywala
- Ukuxhalabisa
- Ukutshatyalaliswa
- Ukujuluka okukhulu
- Umbono ongezantsi
- Ukutshitshisa okanye ukutshitshiswa kwamandla kagesi
- Amaphupha angafanelanga
- Hallucinations
Ugqirha wakho unokunceda ukuphepha le mpawu ngokukugqithisa ngokukwiinkonzo zakho okanye ukuguqula kwiyeza ezahlukeneyo.
> Imithombo:
> Gjestad, D .; Westin, A .; Skoqvoll, E. et al. "Impembelelo yeProteton Pump Inhibitors kwiinkcazo zeSerum zeSerotonin Reuptake Inhibitors eCitalopram, Escitalopram naseSertraline." I-Ther Drug Monit . 2015; 37 (1): 90-97.
> Kelly, K .; Posternak, M .; kunye noJonatan, E. "Ukufezekisa impendulo efanelekileyo: ukuqonda nokulawula iimpembelelo ezichasayo." Iingxoxo zeKlinikhi ye-Neurosci . 2008; 10 (4): 409-418.
> I-Renoir, T. "I-serotonin ekhethiweyo i-reuptake inhibitor yokuxhatshazwa kwengxaki yokulahla ukwelashwa: ukuhlaziywa kobungqina bekliniki kunye neendlela ezinokwenzeka." Front Pharmacol . 2013; 4:45.